24-4-2025

Use of hormones in BRCA carriers: hormonal replacement therapy, oral contraception, ovarian stimulation – is it safe?

Sophie Frank, MD, is a gynecologist specialised in oncology and oncogenetics at Institut Curie, Paris, France. She takes care of women with genetic predisposition associated with high risk of breast and gynecologic cancers, especially in HBOC genes.

Use of hormones in BRCA carriers raises a lot of questions throughout a woman’s life: oral contraception, ovarian stimulation for assisted reproduction, hormonal replacement therapy after menopause. This webinar will present a comprehensive review of literature on these subjects, focusing on benefits and risks of these treatments.

Registration: https://attendee.gotowebinar.com/register/2840662403420956250